Navamedic ASA (OSL:NAVA)
22.50
-1.00 (-4.26%)
May 9, 2025, 4:25 PM CET
Navamedic ASA Revenue
Navamedic ASA had revenue of 132.02M NOK in the quarter ending March 31, 2025, with 9.23% growth. This brings the company's revenue in the last twelve months to 542.59M, up 6.15% year-over-year. In the year 2024, Navamedic ASA had annual revenue of 531.44M with 3.80% growth.
Revenue (ttm)
542.59M
Revenue Growth
+6.15%
P/S Ratio
0.73
Revenue / Employee
12.92M
Employees
42
Market Cap
397.41M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 531.44M | 19.44M | 3.80% |
Dec 31, 2023 | 512.00M | 129.86M | 33.98% |
Dec 31, 2022 | 382.14M | 103.70M | 37.24% |
Dec 31, 2021 | 278.44M | 68.56M | 32.67% |
Dec 31, 2020 | 209.88M | 21.12M | 11.19% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Medistim ASA | 603.92M |
Nordhealth AS | 537.23M |
Photocure ASA | 532.69M |
Vistin Pharma ASA | 440.66M |
Nykode Therapeutics AS | 104.04M |
Hofseth BioCare ASA | 265.54M |
Omda AS | 426.27M |
Gentian Diagnostics ASA | 158.07M |